Cited by 1,452Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 69 of the 71 references it cites were found in a registry or an index.

Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability

Open access

Dahlgren, Karie N., Manelli, Arlene M., Stine, W. Blaine, Baker, Lorinda K., Krafft, Grant A., LaDu, Mary Jo·2002·Journal of Biological Chemistry

DOI 10.1074/jbc.m201750200

Open this paper in CoChat — free account

Abstract

Genetic evidence predicts a causative role for amyloid-beta (A beta) in Alzheimer's disease. Recent debate has focused on whether fibrils (amyloid) or soluble oligomers of A beta are the active species that contribute to neurodegeneration and dementia. We developed two aggregation protocols for the consistent production of stable oligomeric or fibrillar preparations of A beta-(1-42). Here we report that oligomers inhibit neuronal viability 10-fold more than fibrils and approximately 40-fold more than unaggregated peptide, with oligomeric A beta-(1-42)-induced inhibition significant at 10 nm. Under A beta-(1-42) oligomer- and fibril-forming conditions, A beta-(1-40) remains predominantly as unassembled monomer and had significantly less effect on neuronal viability than preparations of A beta-(1-42). We applied the aggregation protocols developed for wild type A beta-(1-42) to A beta-(1-42) with the Dutch (E22Q) or Arctic (E22G) mutations. Oligomeric preparations of the mutations exhibited extensive protofibril and fibril formation, respectively, but were not consistently different from wild type A beta-(1-42) in terms of inhibition of neuronal viability. However, fibrillar preparations of the mutants appeared larger and induced significantly more inhibition of neuronal viability than wild type A beta-(1-42) fibril preparations. These data demonstrate that protocols developed to produce oligomeric and fibrillar A beta-(1-42) are useful in distinguishing the structural and functional differences between A beta-(1-42) and A beta-(1-40) and genetic mutations of A beta-(1-42).

Integrity signals

Registry

Crossref · 10.1074/jbc.m201750200

Cites

69 of 69 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Alzheimer's Disease: Genes, Proteins, and Therapy
Selkoe, D. J. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.741 · Cited by 6,063
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Self-citation
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions
Saudou, F., Finkbeiner, S. M., Devys, D., & Greenberg, M. E. (1998) · Cell · doi:10.1016/s0092-8674(00)81782-1 · Cited by 1,598
Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy
Conway, K. A., Lee, S., Rochet, J., Ding, T. T., Williamson, R. E., & Lansbury, P. T. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.2.571 · Cited by 1,559
Soluble Amyloid β Peptide Concentration as a Predictor of Synaptic Change in Alzheimer's Disease
Lue, L.-F., Kuo, Y.-M., Roher, A. E., Brachova, L., Shen, Y., Sue, L., Beach, T., Kurth, J. H., Rydel, R. E., & Rogers, J. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65184-x · Cited by 1,530
A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N–terminus of β–amyloid
Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., & Lannfelt, L. (1992) · Nature Genetics · doi:10.1038/ng0892-345 · Cited by 1,513
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417

Flagged first, then by citations

Show all 71 references

2 of the 71 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

Tagliavini, 1999, Alzheimer Rep., 2, 28
Miravalle, 2000, J. Biol. Chem., 275, 27110, 10.1016/S0021-9258(19)61486-9 · DOI
Sian, 2000, Biochem. J., 349, 299, 10.1042/bj3490299 · DOI

Sorted by citations

Items 401–500 of 1,002

An Expanded Narrative Review of Neurotransmitters on Alzheimer’s Disease: The Role of Therapeutic Interventions on Neurotransmission
Akyuz, E., Arulsamy, A., Aslan, F. S., Sarisözen, B., Guney, B., Hekimoglu, A., Yilmaz, B. N., Retinasamy, T., & Shaikh, M. F. (2025) · Molecular Neurobiology · doi:10.1007/s12035-024-04333-y · Cited by 69
Amyloid-β Peptide Is a Substrate of the Human 20S Proteasome
Zhao, X., & Yang, J. (2010) · ACS Chemical Neuroscience · doi:10.1021/cn100067e · Cited by 68
Models of membrane‐bound Alzheimer's Abeta peptide assemblies
Shafrir, Y., Durell, S. R., Arispe, N. J., & Guy, H. R. (2010) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22853 · Cited by 69
Interaction between amyloid β‐protein aggregates and membranes
Kakio, A., Yano, Y., Takai, D., Kuroda, Y., Matsumoto, O., Kozutsumi, Y., & Matsuzaki, K. (2004) · Journal of Peptide Science · doi:10.1002/psc.570 · Cited by 68
Extracellular chaperones prevent Aβ42-induced toxicity in rat brains
Cascella, R., Conti, S., Tatini, F., Evangelisti, E., Scartabelli, T., Casamenti, F., Wilson, M. R., Chiti, F., & Cecchi, C. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.04.012 · Cited by 70
Early effects of Aβ 1-42 oligomers injection in mice: Involvement of PI3K/Akt/GSK3 and MAPK/ERK1/2 pathways
Morroni, F., Sita, G., Tarozzi, A., Rimondini, R., & Hrelia, P. (2016) · Behavioural Brain Research · doi:10.1016/j.bbr.2016.08.002 · Cited by 65
Trans-caryophyllene inhibits amyloid β (Aβ) oligomer-induced neuroinflammation in BV-2 microglial cells
Hu, Y., Zeng, Z., Wang, B., & Guo, S. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.07.009 · Cited by 69
Early minor stimulation of microglial TLR2 and TLR4 receptors attenuates Alzheimer's disease–related cognitive deficit in rats: behavioral, molecular, and electrophysiological evidence
Pourbadie, H. G., Sayyah, M., Khoshkholgh-Sima, B., Choopani, S., Nategh, M., Motamedi, F., & Shokrgozar, M. A. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.06.020 · Cited by 68
Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells.
Kania, K., Wijesuriya, H. C., Hladky, S., & Barrand, M. (2011) · Brain Research · doi:10.1016/j.brainres.2011.08.044 · Cited by 63
Design, synthesis and biological evaluation of D-ring opened galantamine analogs as multifunctional anti-Alzheimer agents
Fang, L., Fang, X., Gou, S., Lupp, A., Lenhardt, I., Sun, H., Huang, Z., Chen, Y., Zhang, Y., & Fleck, C. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.02.035 · Cited by 68
Attenuation of β-amyloid induced toxicity by sialic acid-conjugated dendrimeric polymers
Patel, D. A., Henry, J. E., & Good, T. A. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2006.08.008 · Cited by 67
Metallothionein-3 modulates the amyloid β endocytosis of astrocytes through its effects on actin polymerization
Lee, S.-J., Seo, B.-R., & Koh, J. (2015) · Molecular Brain · doi:10.1186/s13041-015-0173-3 · Cited by 67
Activity of translation regulator eukaryotic elongation factor-2 kinase is increased in Parkinson disease brain and its inhibition reduces alpha synuclein toxicity
Jan, A., Jansonius, B., Delaidelli, A., Bhanshali, F., An, Y. A., Ferreira, N., Smits, L. M., Negri, G. L., Schwamborn, J. C., Jensen, P. H., et al. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0554-9 · Cited by 66
“Click Peptides”—Chemical Biology‐Oriented Synthesis of Alzheimer's Disease‐Related Amyloid β Peptide (Aβ) Analogues Based on the “O‐Acyl Isopeptide Method”
Sohma, Y., & Kiso, Y. (2006) · ChemBioChem · doi:10.1002/cbic.200600112 · Cited by 70
Detection of Amyloid-β Oligomers in Human Cerebrospinal Fluid by Flow Cytometry and Fluorescence Resonance Energy Transfer
Santos, A. N., Torkler, S., Nowak, D., Schlittig, C., Goerdes, M., Lauber, T., Trischmann, L., Schaupp, M., Penz, M., Tiller, F.-W., et al. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-11114 · Cited by 66
Edaravone Attenuates the Proinflammatory Response in Amyloid-β-Treated Microglia by Inhibiting NLRP3 Inflammasome-Mediated IL-1β Secretion
Wang, H., Zhang, T., Huang, J., Xiang, J., Chen, J., Fu, J., & Zhao, Y. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000481753 · Cited by 66
Conformational Dynamics of Amyloid β-Protein Assembly Probed Using Intrinsic Fluorescence
Maji, S. K., Amsden, J. J., Rothschild, K. J., Condron, M. M., & Teplow, D. B. (2005) · Biochemistry · doi:10.1021/bi0508284 · Cited by 66
Influence of Multiple Metal Ions on β-Amyloid Aggregation and Dissociation on a Solid Surface
Ryu, J., Girigoswami, K., Ha, C., Ku, S. H., & Park, C. B. (2008) · Biochemistry · doi:10.1021/bi800012e · Cited by 66
Altered synaptic structure in the hippocampus in a mouse model of Alzheimer’s disease with soluble amyloid-β oligomers and no plaque pathology
Price, K. A., Varghese, M., Sowa, A., Yuk, F., Brautigam, H., Ehrlich, M. E., & Dickstein, D. L. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-41 · Cited by 67
Environment‐ and mutation‐dependent aggregation behavior of Alzheimer amyloid β‐protein
Yamamoto, N., Hasegawa, K., Matsuzaki, K., Naiki, H., & Yanagisawa, K. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02459.x · Cited by 67
Dynamic Role of Phospholipases A2 in Health and Diseases in the Central Nervous System
Sun, G. Y., Geng, X. H., Teng, T., Yang, B., Appenteng, M. K., Greenlief, C. M., & Lee, J. C. (2021) · Cells · doi:10.3390/cells10112963 · Cited by 64
The Quest for Small Molecules as Amyloid Inhibiting Therapies for Alzheimer's Disease
Amijee, H., & Scopes, D. I. C. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1044 · Cited by 65
Tauroursodeoxycholic acid prevents E22Q Alzheimer’s Aβ toxicity in human cerebral endothelial cells
Viana, R. J. S., Nunes, A. F., Castro, R. E., Ramalho, R. M., Meyerson, J. L., Fossati, S., Ghiso, J. A., Rostagno, A. A., & Rodrigues, C. M. P. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-8746-x · Cited by 64
Poly-N-methylated Amyloid β-Peptide (Aβ) C-Terminal Fragments Reduce Aβ Toxicity in Vitro and in Drosophila melanogaster
Bose, P. P., Chatterjee, U., Nerelius, C., Govender, T., Norström, T., Gogoll, A., Sandegren, A., Göthelid, E., Johansson, J., & Arvidsson, P. I. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901092h · Cited by 64
Comparative Molecular Dynamics Studies of Wild-Type and Oxidized Forms of Full-Length Alzheimer Amyloid β-Peptides Aβ(1−40) and Aβ(1−42)
Triguero, L., Singh, R. R. P., & Prabhakar, R. S. (2008) · The Journal of Physical Chemistry B · doi:10.1021/jp801168v · Cited by 62
Oligomeric Amyloid-β Inhibits the Proteolytic Conversion of Brain-derived Neurotrophic Factor (BDNF), AMPA Receptor Trafficking, and Classical Conditioning
Zheng, Z., Sabirzhanov, B. E., & Keifer, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.150821 · Cited by 68
C-Glycosylflavones Alleviate Tau Phosphorylation and Amyloid Neurotoxicity through GSK3β Inhibition
Liang, Z., Zhang, B., Su, W., Williams, P. G., & Li, Q. X. (2016) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.6b00059 · Cited by 65
Insights into the Molecular Mechanisms of Alzheimer’s and Parkinson’s Diseases with Molecular Simulations: Understanding the Roles of Artificial and Pathological Missense Mutations in Intrinsically Disordered Proteins Related to Pathology
Coskuner‐Weber, O., & Uversky, V. N. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020336 · Cited by 71
N‐terminal truncated pyroglutamyl β amyloid peptide Aβpy3‐42 shows a faster aggregation kinetics than the full‐length Aβ1‐42
D’Arrigo, C., Tabaton, M., & Perico, A. (2009) · Biopolymers · doi:10.1002/bip.21271 · Cited by 63
Sporadic inclusion body myositis: a continuing puzzle
Needham, M., & Mastaglia, F. L. (2007) · Neuromuscular Disorders · doi:10.1016/j.nmd.2007.11.001 · Cited by 63
Alzheimer?s Disease: Soluble Oligomeric A?(1?40) Peptide in Membrane Mimic Environment from Solution NMR and Circular Dichroism Studies
Mandal, P. K., & Pettegrew, J. W. (2004) · Neurochemical Research · doi:10.1007/s11064-004-7035-1 · Cited by 62
Amyloid-β oligomers regulate the properties of human neural stem cells through GSK-3β signaling
Lee, I.-S., Jung, K., Kim, I., & Park, K. I. (2013) · Experimental & Molecular Medicine · doi:10.1038/emm.2013.125 · Cited by 63
Intrahippocampal injection of Aβ 1-42 inhibits neurogenesis and down-regulates IFN-γ and NF-κB expression in hippocampus of adult mouse brain
Zheng, M., Liu, J., Ruan, Z., Tian, S., Ma, Y., Zhu, J., & Li, G. (2013) · Amyloid · doi:10.3109/13506129.2012.755122 · Cited by 62
A Safe, Blood-Brain Barrier Permeable Triphenylmethane Dye Inhibits Amyloid-β Neurotoxicity by Generating Nontoxic Aggregates
Wong, H. E., Qi, W., Choi, H., Fernández, E., & Kwon, I. (2011) · ACS Chemical Neuroscience · doi:10.1021/cn200056g · Cited by 64
Endocytic pathways mediating oligomeric Aβ42 neurotoxicity
Yu, C., Nwabuisi‐Heath, E., Laxton, K., & LaDu, M. J. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-19 · Cited by 63
Amyloid-Binding Alcohol Dehydrogenase (ABAD) Inhibitors for the Treatment of Alzheimer's Disease.
Morsy, A., & Trippier, P. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b01530 · Cited by 54
Discovery of PT-65 as a highly potent and selective Proteolysis-targeting chimera degrader of GSK3 for treating Alzheimer's disease
Qu, L., Li, S., Ji, L., Luo, S., Ding, M., Yin, F., Wang, C., Luo, H., Lu, D., Liu, X., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113889 · Cited by 61
Aggregation and fibril morphology of the Arctic mutation of Alzheimer’s Aβ peptide by CD, TEM, STEM and in situ AFM
Norlin, N., Hellberg, M., Filippov, A. V., Sousa, A. A., Gröbner, G., Leapman, R. D., Almqvist, N., & Antzutkin, O. N. (2012) · Journal of Structural Biology · doi:10.1016/j.jsb.2012.06.010 · Cited by 62
Ligand-Based Design, Synthesis, and Biological Evaluation of 2-Aminopyrimidines, a Novel Series of Receptor for Advanced Glycation End Products (RAGE) Inhibitors
Han, Y. T., Choi, G.-I., Son, D., Kim, N., Yun, H., Lee, S.-J., Chang, D. J., Hong, H., Kim, H. Y., Ha, H.-J., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300172z · Cited by 61
Role of water‐soluble amyloid‐β in the pathogenesis of Alzheimer's disease
Tabaton, M., & Piccini, A. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00428.x · Cited by 65
Inhibition of AMPA receptor trafficking at hippocampal synapses by β-amyloid oligomers: the mitochondrial contribution
Rui, Y., Gu, J., Yu, K., Hartzell, H. C., & Zheng, J. Q. (2010) · Molecular Brain · doi:10.1186/1756-6606-3-10 · Cited by 62
Differential Processing of Amyloid-β Precursor Protein Directs Human Embryonic Stem Cell Proliferation and Differentiation into Neuronal Precursor Cells
Porayette, P., Gallego, M. J., Kaltcheva, M. M., Bowen, R. L., Meethal, S. V., & Atwood, C. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.026328 · Cited by 65
The effects of betulinic acid on neurobehavioral activity, electrophysiology and histological changes in an animal model of the Alzheimer’s disease
Navabi, S. P., Sarkaki, A., Mansouri, E., Badavi, M., Ghadiri, A., & Farbood, Y. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.10.002 · Cited by 60
Direct in Vivo Intracellular Selection of Conformation-sensitive Antibody Domains Targeting Alzheimer's Amyloid-β Oligomers
Meli, G., Visintin, M., Cannistraci, I., & Cattaneo, A. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.01.061 · Cited by 64
3D-visualization of amyloid-β oligomer interactions with lipid membranes by cryo-electron tomography
Tian, Y., Liang, R., Kumar, A., Szwedziak, P., & Viles, J. H. (2021) · Chemical Science · doi:10.1039/d0sc06426b · Cited by 59
Amyloid β peptide directly impairs pineal gland melatonin synthesis and melatonin receptor signaling through the ERK pathway
Cecon, E., Chen, M., Marçola, M., Fernandes, P. A. C. M., Jockers, R., & Markus, R. P. (2015) · The FASEB Journal · doi:10.1096/fj.14-265678 · Cited by 63
Discovery and Structure Activity Relationship of Small Molecule Inhibitors of Toxic β-Amyloid-42 Fibril Formation
Kroth, H., Ansaloni, A., Varisco, Y., Jan, A., Sreenivasachary, N., Rezaei‐Ghaleh, N., Giriens, V., Lohmann, S., López-Deber, M. P., Adolfsson, O., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.357665 · Cited by 62
Stress Granules Modulate SYK to Cause Microglial Cell Dysfunction in Alzheimer's Disease
Ghosh, S., & Geahlen, R. L. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.09.053 · Cited by 62
Mechanisms of the inhibitory effects of amyloid β-protein on synaptic plasticity
Rowan, M. J., Klyubin, I. V., Wang, Q., & Anwyl, R. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.06.020 · Cited by 60
Combining the rapid MTT formazan exocytosis assay and the MC65 protection assay led to the discovery of carbazole analogs as small molecule inhibitors of Aβ oligomer-induced cytotoxicity
Hong, H., Maezawa, I., Yao, N., Xu, B., Díaz-Avalos, R., Rana, S., Hua, D. H., Cheng, R. H., Lam, K. S., & Jin, L. (2006) · Brain Research · doi:10.1016/j.brainres.2006.10.093 · Cited by 60
Proteinase-Activated Receptor-2 Exerts Protective and Pathogenic Cell Type-Specific Effects in Alzheimer’s Disease
Afkhami-Goli, A., Noorbakhsh, F., Keller, A. J., Vergnolle, N., Westaway, D. A., Jhamandas, J. H., Andrade‐Gordon, P., Hollenberg, M. D., Arab, H.-A., Dyck, R. H., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5493 · Cited by 60
Neurotrophin receptor p75 mediates amyloid β-induced tau pathology
Shen, L.-L., Li, W.-W., Xu, Y.-L., Gao, S.-H., Xu, M.-Y., Bu, X.-L., Liu, Y.-H., Wang, J., Zhu, J., Zeng, F., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104567 · Cited by 59
Geniposide Ameliorates Cognitive Deficits by Attenuating the Cholinergic Defect and Amyloidosis in Middle-Aged Alzheimer Model Mice
Zhao, C., Zhang, H., Li, H., Lv, C., Liu, X., Li, Z., Xin, W., Wang, Y., & Zhang, W. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.12.002 · Cited by 59
Small molecule inhibitors of Abetaassembly
LeVine, H. (2007) · Amyloid · doi:10.1080/13506120701461020 · Cited by 58
Spinosin, a C-Glucosylflavone, from Zizyphus jujuba var. spinosa Ameliorates Aβ1–42 Oligomer-Induced Memory Impairment in Mice
Ko, S. Y., Lee, H. E., Park, S. J., Jeon, S. J., Kim, B., Gao, Q., Jang, D. S., & Ryu, J. H. (2015) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2014.110 · Cited by 60
Preventive and therapeutic types of environmental enrichment counteract beta amyloid pathology by different molecular mechanisms
Herring, A., Lewejohann, L., Panzer, A.-L., Donath, A., Kröll, O., Sachser, N., Paulus, W., & Keyvani, K. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.03.007 · Cited by 63
Amyloid β-protein stimulates trafficking of cholesterol and caveolin-1 from the plasma membrane to the Golgi complex in mouse primary astrocytes
Igbavboa, U., Sun, G. Y., Weisman, G. A., He, Y., & Wood, W. G. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.04.049 · Cited by 64
Amyloid Precursor Protein (APP) Mediated Regulation of Ganglioside Homeostasis Linking Alzheimer's Disease Pathology with Ganglioside Metabolism
Grimm, M. O. W., Zinser, E. G., Grösgen, S., Hundsdörfer, B., Rothhaar, T. L., Burg, V. K., Kaestner, L., Bayer, T. A., Lipp, P., Müller, U., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034095 · Cited by 59
Inhibitor Discovery Targeting the Intermediate Structure of β-Amyloid Peptide on the Conformational Transition Pathway: Implications in the Aggregation Mechanism of β-Amyloid Peptide
Liu, D., Xu, Y., Yu, F., Liu, H., Shen, X., Chen, K., Ma, J., & Jiang, H. (2006) · Biochemistry · doi:10.1021/bi060955f · Cited by 59
β-Amyloid Peptide Activates Non-α7 Nicotinic Acetylcholine Receptors in Rat Basal Forebrain Neurons
Fu, W., & Jhamandas, J. H. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00616.2003 · Cited by 59
Thioflavins released from nanoparticles target fibrillar amyloid β in the hippocampus of APP/PS1 transgenic mice
Siegemund, T., Paulke, B. ‐., Schmiedel, H., Bordag, N., Hoffmann, A. H., Harkany, T., Tanila, H., Kacza, J., & Härtig, W. (2005) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2005.11.012 · Cited by 60
Microglial Amyloid- β 1-40 Phagocytosis Dysfunction Is Caused by High-Mobility Group Box Protein-1: Implications for the Pathological Progression of Alzheimer’s Disease
Takata, K., Takada, T., Ito, A., Asai, M., Tawa, M., Saito, Y., Ashihara, E., Tomimoto, H., Kitamura, Y., & Shimohama, S. (2012) · International Journal of Alzheimer s Disease · doi:10.1155/2012/685739 · Cited by 60
Misfolding of the amyloid β‐protein: A molecular dynamics study
Flöck, D., Colacino, S., Colombo, G., & Nola, A. D. (2005) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.20683 · Cited by 58
Antibody-based therapy in Alzheimer's disease
Pul, R., Dodel, R. C., & Stangel, M. (2011) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2011.552884 · Cited by 59
Andrographolide attenuates microglia-mediated Aβ neurotoxicity partially through inhibiting NF-κB and JNK MAPK signaling pathway
Yang, R., Liu, S., Zhou, J., Bu, S.-H., & Zhang, J. (2017) · Immunopharmacology and immunotoxicology · doi:10.1080/08923973.2017.1344989 · Cited by 50
The neuroprotective role of melatonin against amyloidβpeptide injected mice
Masilamoni, J. G., Jesudason, E. P., Dhandayuthapani, S., Ashok, B. S., Vignesh, S., Walter, C. E. J., Paul, S. F. D., & Rajadas, J. (2008) · Free Radical Research · doi:10.1080/10715760802277388 · Cited by 60
The effects of amyloid-β42 oligomer on the proliferation and activation of astrocytes in vitro
Hou, L., Liu, Y., Wang, X., Ma, H., He, J., Zhang, Y., Yu, C.-H., Guan, W., & Ma, Y.-H. (2011) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-011-9439-y · Cited by 57
Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation.
Mandal, M., Zhu, Z.-N., Cumming, J., Liu, X.-X., Strickland, C., Mazzola, R., Caldwell, J., Leach, P., Grzelak, M., Hyde, L., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301039c · Cited by 51
Amyloid-β fibril disruption by C60—molecular guidance for rational drug design
Andújar, S. A., Lugli, F., Höfinger, S., Enriz, R. D., & Zerbetto, F. (2012) · Physical Chemistry Chemical Physics · doi:10.1039/c2cp40680b · Cited by 57
α-synuclein induced synapse damage is enhanced by amyloid-β1-42
Bate, C., Gentleman, S., & Williams, A. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-55 · Cited by 55
Evaluation of the Cerebrospinal Fluid Amyloid-β1-42/Amyloid-β1-40 Ratio Measured by Alpha-LISA to Distinguish Alzheimer's Disease from Other Dementia Disorders
Nutu, M., Zetterberg, H., Londos, E., Minthon, L., Nägga, K., Blennow, K., Hansson, O., & Öhrfelt, A. (2013) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000353442 · Cited by 57
Novel Anti-Alzheimer's Dimer Bis(7)-Cognitin: Cellular and Molecular Mechanisms of Neuroprotection Through Multiple Targets
Li, W., Mak, S., Jiang, H., Wang, Q., Pang, Y., Chen, K., & Han, Y. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.10.040 · Cited by 57
Amyloid β oligomers elicit mitochondrial transport defects and fragmentation in a time-dependent and pathway-specific manner
Rui, Y., & Zheng, J. Q. (2016) · Molecular Brain · doi:10.1186/s13041-016-0261-z · Cited by 57
Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium
d’Uscio, L. V., He, T., & Katušić, Z. S. (2016) · Physiology · doi:10.1152/physiol.00021.2016 · Cited by 57
Not All Stressors Are Equal: Mechanism of Stressors on RPE Cell Degeneration
Tong, Y., & Wang, S. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.591067 · Cited by 56
Interaction with Amyloid β Peptide Compromises the Lipid Binding Function of Apolipoprotein E
Tamamizu‐Kato, S., Cohen, J. K., Drake, C. B., Kosaraju, M. G., Drury, J., & Narayanaswami, V. (2008) · Biochemistry · doi:10.1021/bi702097s · Cited by 56
In vitro fibrillization of Alzheimer’s amyloid-β peptide (1-42)
Tiiman, A., Krishtal, J., Palumaa, P., & Tõugu, V. (2015) · AIP Advances · doi:10.1063/1.4921071 · Cited by 62
New Method Based on Capillary Electrophoresis with Laser-Induced Fluorescence Detection (CE-LIF) to Monitor Interaction between Nanoparticles and the Amyloid-β Peptide
Brambilla, D., Verpillot, R., Taverna, M., Kimpe, L. D., Droumaguet, B. L., Nicolas, J., Canovi, M., Gobbi, M., Mantegazza, F., Salmona, M., et al. (2010) · Analytical Chemistry · doi:10.1021/ac102045x · Cited by 59
Myeloid differentiation factor 88-deficient bone marrow cells improve Alzheimer’s disease-related symptoms and pathology
Hao, W., Liu, Y., Liu, S., Walter, S., Grimm, M. O. W., Kiliaan, A. J., Penke, B., Hartmann, T., Rübe, C. E., Menger, M. D., et al. (2010) · Brain · doi:10.1093/brain/awq325 · Cited by 54
Thrombospondin-1 prevents amyloid beta–mediated synaptic pathology in Alzheimer's disease
Son, S. M., Nam, D. W., Cha, M.-Y., Kim, K. H., Byun, J., Ryu, H., & Mook‐Jung, I. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.09.005 · Cited by 57
Soluble Oligomers Require a Ganglioside to Trigger Neuronal Calcium Overload
Cascella, R., Evangelisti, E., Bigi, A., Becatti, M., Fiorillo, C., Stefani, M., Chiti, F., & Cecchi, C. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170340 · Cited by 57
Comparing the folding free‐energy landscapes of Aβ42 variants with different aggregation properties
Mitternacht, S., Staneva, I., Härd, T., & Irbäck, A. (2010) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22775 · Cited by 57
EGb761 Provides a Protective Effect against Aβ1-42 Oligomer-Induced Cell Damage and Blood-Brain Barrier Disruption in an In Vitro bEnd.3 Endothelial Model
Wan, W., Cao, L., Liu, L., Kalionis, B., Chen, C., Tai, X., Li, Y., & Xia, S.-J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113126 · Cited by 55
Recombinant apoptin multimers kill tumor cells but are nontoxic and epitope-shielded in a normal-cell-specific fashion
Zhang, Y. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00188-5 · Cited by 55
Cyclic Peptides as Inhibitors of Amyloid Fibrillation
Luo, J., & Abrahams, J. P. (2014) · Chemistry - A European Journal · doi:10.1002/chem.201304253 · Cited by 56
Biophysical Characterization of Aβ42 C-Terminal Fragments: Inhibitors of Aβ42 Neurotoxicity
Li, H., Monien, B. H., Fradinger, E. A., Urbanc, B., & Bitan, G. (2010) · Biochemistry · doi:10.1021/bi902075h · Cited by 55
Yeast as a model for studying Alzheimer's disease
Bharadwaj, P., Martins, R. N., & Macreadie, I. G. (2010) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2010.00658.x · Cited by 56
The Molecular Assembly of Amyloid Aβ Controls Its Neurotoxicity and Binding to Cellular Proteins
Manzoni, C., Colombo, L., Bigini, P., Diana, V., Cagnotto, A., Messa, M., Lupi, M., Bonetto, V., Pignataro, M., Airoldi, C., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024909 · Cited by 55
Network-driven anomalous transport is a fundamental component of brain microvascular dysfunction
Goirand, F., Borgne, T. L., & Lorthois, S. (2021) · Nature Communications · doi:10.1038/s41467-021-27534-8 · Cited by 55
The hunt for brain Aβ oligomers by peripherally circulating multi-functional nanoparticles: Potential therapeutic approach for Alzheimer disease
Mancini, S., Minniti, S., Gregori, M., Sancini, G., Cagnotto, A., Couraud, P., Ordóñez‐Gutiérrez, L., Wandosell, F. G., Salmona, M., & Re, F. (2015) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2015.09.003 · Cited by 54
Deleterious effects of soluble amyloid-β oligomers on multiple steps of synaptic vesicle trafficking
Park, J., Jang, M., & Chang, S. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.03.004 · Cited by 57
Amelioration of amyloid load by anti-Aβ single-chain antibody in Alzheimer mouse model
Fukuchi, K., Accavitti-Loper, M. A., Kim, H. D., Tahara, K., Cao, Y., Lewis, T. L., Caughey, R. C., Kim, H., & Lalonde, R. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.03.145 · Cited by 54
Mechanistic Investigation of the Inhibition of Aβ42 Assembly and Neurotoxicity by Aβ42 C-Terminal Fragments
Li, H., Monien, B. H., Lomakin, A., Zemel, R., Fradinger, E. A., Tan, M., Spring, S. M., Urbanc, B., Xie, C.-W., Benedek, G. B., et al. (2010) · Biochemistry · doi:10.1021/bi100773g · Cited by 54
Behavioural and cellular effects of exogenous amyloid-β peptides in rodents
Chambon, C., Wegener, N., Gravius, A., & Danysz, W. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.08.024 · Cited by 61
Magnetite-Amyloid-β deteriorates activity and functional organization in an in vitro model for Alzheimer’s disease
Teller, S., Tahirbegi, I. B., Mir, M., Samitier, J., & Soriano, J. (2015) · Scientific Reports · doi:10.1038/srep17261 · Cited by 54
The Solution Assembly of Biological Molecules Using Ion Mobility Methods: From Amino Acids to Amyloid β-Protein
Bleiholder, C., & Bowers, M. T. (2017) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-071114-040304 · Cited by 54
Nanogels of dual inhibitor-modified hyaluronic acid function as a potent inhibitor of amyloid β-protein aggregation and cytotoxicity
Jiang, Z., Dong, X., Yan, X., Liu, Y., Zhang, L., & Sun, Y. P. (2018) · Scientific Reports · doi:10.1038/s41598-018-21933-6 · Cited by 56
Proinflammatory cytokine interferon‐γ increases induction of indoleamine 2,3‐dioxygenase in monocytic cells primed with amyloid β peptide 1–42: implications for the pathogenesis of Alzheimer’s disease
Yamada, A., Akimoto, H., Kagawa, S., Guillemin, G. J., & Takikawa, O. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06175.x · Cited by 58
Anti-ADDL antibodies differentially block oligomer binding to hippocampal neurons
Shughrue, P. J., Acton, P. J., Breese, R., Zhao, W., Chen-Dodson, E., Hepler, R. W., Wolfe, A. L., Matthews, M., Heidecker, G. J., Joyce, J. G., et al. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.04.003 · Cited by 53
Recent advances in small molecular near-infrared fluorescence probes for a targeted diagnosis of the Alzheimer disease
Liu, Y., Zhuang, D., Wang, J., Huang, H., Li, R., Wu, C., Deng, Y., Hu, G., & Guo, B. (2022) · The Analyst · doi:10.1039/d2an01327d · Cited by 53

Authors: Dahlgren, K. N., Manelli, A. M., Stine, W. B., Baker, L. K., Krafft, G. A., & LaDu, M. J.
Affiliations: Northwestern University (US)
Corresponding author: LaDu, Mary Jo
ORCID: Baker, Lorinda K.
LaDu, Mary Jo
Venue: Journal of Biological Chemistry
Publisher: Elsevier BV
Published: 2002-08
Volume: 277
Issue: 35
Pages: 32046-32053
ISSN: 0021-9258 (ISSN-L)
DOI: 10.1074/jbc.m201750200
OpenAlex: W2168025729
Cited by: 1,452
References: 71
Citations by year: 2026: 25 · 2025: 33 · 2024: 40 · 2023: 46 · 2022: 45 · 2021: 47 · 2020: 49 · 2019: 55 · 2018: 65 · 2017: 58 · 2016: 61 · 2015: 70 · 2014: 78 · 2013: 86 · 2012: 86
FWCI: 22.78
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor, 6658 d)
Locations: Journal of Biological Chemistry (publishedVersion, cc-by)
PubMed (publishedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: amyloid-beta, amyloid-beta oligomers, amyloid fibrils, Alzheimer's disease, neuronal viability, peptide aggregation, protofibrils, neurotoxicity
MeSH terms: Alzheimer Disease, Cell Survival, Humans, Neuroblastoma, Neurons, Peptide Fragments, Tumor Cells, Cultured, Amyloid beta-Peptides, Microscopy, Atomic Force

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Oligomeric and Fibrillar Species of Amyloid-β Peptides Differentially Affect Neuronal Viability

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks